How many institutions held TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value in Q2 2021?

70 institutional investors reported TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value for Q2 2021. Use the holders table for investor-level position and value details.

TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI)

Q: What does CUSIP 89455T109 represent in this 13F holders report?

CUSIP 89455T109 is the security identifier for TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value used to aggregate holder disclosures.

CUSIP: 89455T109

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common stock, $0.001 par value
Shares outstanding: 63,703,704
Total 13F shares: 13,009,799
Share change: +13,009,620
Total reported value: $406,683,468
Price per share: $31.26
Number of holders: 70
Value change: +$406,677,512
Number of buys: 69

Quarterly Holders Quick Answers

What is CUSIP 89455T109?
CUSIP 89455T109 identifies TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 89455T109:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
CWM, LLC	13F	Company	0%	179	$6,000	—	31 Mar 2021	13F

Institutional Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) as of Q2 2021

As of 30 Jun 2021, TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) was held by 70 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,009,799 shares. The largest 10 holders included ALLIANCEBERNSTEIN L.P., PERCEPTIVE ADVISORS LLC, NEXT CENTURY GROWTH INVESTORS LLC, VANGUARD GROUP INC, KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, BlackRock Inc., JANUS HENDERSON GROUP PLC, FMR LLC, JENNISON ASSOCIATES LLC, and FEDERATED HERMES, INC.. This page lists 71 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Q2 2021 holders

Holder diff

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.